{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:24:22Z","timestamp":1782969862542,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clinbiochem.2021.05.004","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T21:49:42Z","timestamp":1620769782000},"page":"66-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Urine toxicology screening by liquid chromatography time-of-flight mass spectrometry in a quaternary hospital setting"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1993-6779","authenticated-orcid":false,"given":"Jeffrey D.","family":"Pope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion J.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf H.","family":"Drummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans G.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2021.05.004_b0005","unstructured":"Standards Australia. AS\/NZS 4308:2008 Procedures for specimen collection and the detection and quantitation of drugs of abuse in urine. 2008."},{"issue":"7","key":"10.1016\/j.clinbiochem.2021.05.004_b0010","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/dta.2120","article-title":"Targeted and non-targeted drug screening in whole blood by UHPLC-TOF-MS with data-independent acquisition","volume":"9","author":"Mollerup","year":"2017","journal-title":"Drug Test Anal."},{"issue":"9","key":"10.1016\/j.clinbiochem.2021.05.004_b0015","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/jat\/bkt083","article-title":"Screening and Confirmation of 62 Drugs of Abuse and Metabolites in Urine by Ultra-High-Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry","volume":"37","author":"Tsai","year":"2013","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.clinbiochem.2021.05.004_b0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chroma.2016.05.002","article-title":"Doping control analysis of 46 polar drugs in horse plasma and urine using a \u2018dilute-and-shoot\u2019 ultra high performance liquid chromatography-high resolution mass spectrometry approach","volume":"1451","author":"Kwok","year":"2016","journal-title":"J Chromatogr A."},{"key":"10.1016\/j.clinbiochem.2021.05.004_b0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jchromb.2016.05.010","article-title":"Rapid screening for drugs of abuse in biological fluids by ultra high performance liquid chromatography\/Orbitrap mass spectrometry","volume":"1027","author":"Jagerdeo","year":"2016","journal-title":"J Chromatogr B."},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.05.004_b0030","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/dta.2039","article-title":"Liquid chromatography-quadrupole-time-of-flight mass spectrometry screening procedure for urine samples in forensic casework compared to gas chromatography-mass spectrometry","volume":"9","author":"Fels","year":"2017","journal-title":"Drug Test Anal."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.05.004_b0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jat\/bku134","article-title":"Comparison of Drug Detection by Three Quadrupole Time-of-Flight Mass Spectrometry Platforms","volume":"39","author":"Marin","year":"2015","journal-title":"J Anal Toxicol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2021.05.004_b0040","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/15563650.2012.713108","article-title":"Role of liquid chromatography-high-resolution mass spectrometry (LC-HR\/MS) in clinical toxicology","volume":"50","author":"Wu","year":"2012","journal-title":"Clin Toxicol (Phila)."},{"issue":"2-3","key":"10.1016\/j.clinbiochem.2021.05.004_b0045","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.forsciint.2006.05.021","article-title":"Validation of new methods","volume":"165","author":"Peters","year":"2007","journal-title":"Forensic Sci Int."},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.05.004_b0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0009-9120(87)80076-0","article-title":"Rapid drug screening using toxi-lab\u00ae extraction followed by capillary gas chromatography\/mass spectroscopy","volume":"20","author":"Chia","year":"1987","journal-title":"Clin Biochem."},{"issue":"8","key":"10.1016\/j.clinbiochem.2021.05.004_b0055","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/jat\/bkt071","article-title":"Drug Screening in Medical Examiner Casework by High-Resolution Mass Spectrometry (UPLC\u2013MSE-TOF)","volume":"37","author":"Rosano","year":"2013","journal-title":"J Anal Toxicol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2021.05.004_b0060","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/bja\/48.10.1017","article-title":"Metabolism of lorazepam","volume":"48","author":"ELLIOTT","year":"1976","journal-title":"Br J Anaesth."},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.05.004_b0065","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jat\/bkx026","article-title":"Developing a UHPLC\u2013QTOF-MS and Automated Library Search Method for Screening Drugs and Toxic Compounds in Postmortem Specimens","volume":"41","author":"Liu","year":"2017","journal-title":"J Anal Toxicol."},{"key":"10.1016\/j.clinbiochem.2021.05.004_b0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinms.2017.08.002","article-title":"Detection of drugs of abuse in urine using the Bruker Toxtyper\u2122: Experiences in a routine clinical laboratory setting","volume":"4-5","author":"Ott","year":"2017","journal-title":"Clin Mass Spectrom."},{"issue":"10069","key":"10.1016\/j.clinbiochem.2021.05.004_b0075","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0140-6736(17)30281-7","article-title":"Acute toxic effects related to 4-fluoroamphetamine","volume":"389","author":"Wijers","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.clinbiochem.2021.05.004_b0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/7854_2016_64","article-title":"Pharmacology and Toxicology of N-Benzylphenethylamine (\u201cNBOMe\u201d) Hallucinogens","volume":"32","author":"Halberstadt","year":"2017","journal-title":"Curr Top Behav Neurosci."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.05.004_b0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.psym.2014.11.002","article-title":"Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature","volume":"56","author":"Suzuki","year":"2015","journal-title":"Psychosomatics."},{"key":"10.1016\/j.clinbiochem.2021.05.004_b0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnins.2020.00078","article-title":"NBOMes-Highly Potent and Toxic Alternatives of LSD","volume":"14","author":"Zawilska","year":"2020","journal-title":"Front Neurosci."},{"issue":"17","key":"10.1016\/j.clinbiochem.2021.05.004_b0095","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.4155\/bio.14.192","article-title":"Methods for urine drug testing using one-step dilution and direct injection in combination with LC-MS\/MS and LC-HRMS","volume":"6","author":"Beck","year":"2014","journal-title":"Bioanalysis."},{"issue":"9","key":"10.1016\/j.clinbiochem.2021.05.004_b0100","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jat\/bks071","article-title":"Evaluation of High-Resolution Mass Spectrometry for Urine Toxicology Screening in a Pain Management Setting","volume":"36","author":"Crews","year":"2012","journal-title":"J Anal Toxicol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2021.05.004_b0105","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1373\/clinchem.2014.222976","article-title":"Liquid Chromatography High-Resolution TOF Analysis: Investigation of MSE for Broad-Spectrum Drug Screening","volume":"60","author":"Chindarkar","year":"2014","journal-title":"Clin Chem."},{"key":"10.1016\/j.clinbiochem.2021.05.004_b0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jchromb.2016.06.036","article-title":"LC-HR-MS\/MS standard urine screening approach: Pros and cons of automated on-line extraction by turbulent flow chromatography versus dilute-and-shoot and comparison with established urine precipitation","volume":"1043","author":"Helfer","year":"2017","journal-title":"J Chromatogr B."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.05.004_b0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0004563216651646","article-title":"Analysis of legal high materials by ultra-performance liquid chromatography with time of flight mass spectrometry as part of a toxicology vigilance system: what are the most popular novel psychoactive substances in the UK?","volume":"54","author":"Ford","year":"2017","journal-title":"Ann Clin Biochem."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021001454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021001454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:57:35Z","timestamp":1757865455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912021001454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":23,"alternative-id":["S0009912021001454"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.05.004","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine toxicology screening by liquid chromatography time-of-flight mass spectrometry in a quaternary hospital setting","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}